Adiponectin-mediated analgesia and anti-inflammatory effects in rat

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Iannitti, Tommaso ^a,b   Graham, Annette ^a   Dolan, Sharron ^a  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; MESSENGER RNA; RECOMBINANT ADIPONECTIN; UNCLASSIFIED DRUG; ADIPONECTIN RECEPTOR; ADIPONECTIN RECEPTOR 1, RAT; ADIPONECTIN RECEPTOR 2, RAT; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; CARRAGEENAN; RECOMBINANT PROTEIN;

ADULT; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARRAGEENAN-INDUCED PAW EDEMA; CONTROLLED STUDY; DRUG DOSE COMPARISON; GENE EXPRESSION; HYPERALGESIA; INFLAMMATORY PAIN; INTRAPLANTAR DRUG ADMINISTRATION; LOW DRUG DOSE; LUMBAR SPINAL CORD; MALE; NONHUMAN; PAIN THRESHOLD; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANALGESIA; ANIMAL; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG EFFECTS; INFLAMMATION; INTRASPINAL DRUG ADMINISTRATION; METABOLISM; PAIN MEASUREMENT; SPINAL CORD; WISTAR RAT;

ADIPONECTIN; ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CARRAGEENAN; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERALGESIA; INFLAMMATION; INJECTIONS, SPINAL; MALE; PAIN MANAGEMENT; PAIN MEASUREMENT; RATS; RATS, WISTAR; RECEPTORS, ADIPONECTIN; RECOMBINANT PROTEINS; SPINAL CORD;

EID: 84944754743     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0136819     Document Type: Article

References (46)

1. Landskroner-Eiger S, Qian B, Muise ES, Nawrocki AR, Berger JP, Fine EJ, et al. Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo. Clin Cancer Res. 2009; 15(10):3265-76. Epub 2009/05/19. 1078-0432.CCR-08-2649 [pii] doi: 10.1158/1078-0432.CCR-08-2649 PMID: 19447867.
2. Rajala MW, Scherer PE. Minireview: The adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology. 2003; 144(9):3765-73. Epub 2003/08/23. PMID: 12933646.
3. Ajuwon KM, Spurlock ME. Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am J Physiol Regul Integr Comp Physiol. 2005; 288(5):R1220-5. Epub 2004/12/18. 00397.2004 [pii] doi: 10.1152/ajpregu.00397.2004 PMID: 15604306.
4. Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta. 2007; 380(1-2):24-30. Epub 2007/03/09. S0009-8981(07)00032-0 [pii] doi: 10.1016/j.cca.2007.01.026 PMID: 17343838.
5. Takemura Y, Walsh K, Ouchi N. Adiponectin and cardiovascular inflammatory responses. Current atherosclerosis reports. 2007; 9(3):238-43. Epub 2008/02/05. PMID: 18241619.
6. Lee SW, Kim JH, Park MC, Park YB, Lee SK. Adiponectin mitigates the severity of arthritis in mice with collagen-induced arthritis. Scand J Rheumatol. 2008; 37(4):260-8. Epub 2008/07/10. 794851905 [pii] doi: 10.1080/03009740801910346 PMID: 18612926.
7. Peterlin BL, Alexander G, Tabby D, Reichenberger E. Oligomerization state-dependent elevations of adiponectin in chronic daily headache. Neurology. 2008; 70(20):1905-11. Epub 2008/05/14. 70/20/ 1905 [pii] doi: 10.1212/01.wnl.0000312278.40250.6e PMID: 18474846.
8. Hong SJ, Seo HS, Rha SW, Oh DJ, Kwon JA, Lee KN, et al. Decrease in plasma adiponectin concentrations in patients with variant angina pectoris. Circ J. 2006; 70(4):414-8. Epub 2006/03/28. PMID: 16565557.
9. Maruyoshi H, Kojima S, Otsuka F, Funahashi T, Kaikita K, Sugiyama S, et al. Hypoadiponectinemia is associated with coronary artery spasm in men. Circ J. 2005; 69(9):1154-6. Epub 2005/08/30. JST. JSTAGE/circj/69.1154 [pii]. PMID: 16127204.
10. Thundyil J, Pavlovski D, Sobey CG, Arumugam TV. Adiponectin receptor signalling in the brain. Br J Pharmacol. 2012; 165(2):313-27. Epub 2011/07/02. doi: 10.1111/j.1476-5381.2011.01560.x PMID: 21718299; PubMed Central PMCID: PMC3268187.
11. Hoyda TD, Fry M, Ahima RS, Ferguson AV. Adiponectin selectively inhibits oxytocin neurons of the paraventricular nucleus of the hypothalamus. J Physiol. 2007; 585(Pt 3):805-16. Epub 2007/10/20. jphysiol.2007.144519 [pii] doi: 10.1113/jphysiol.2007.144519 PMID: 17947308.
12. Maddineni S, Metzger S, Ocon O, Hendricks G 3rd, Ramachandran R. Adiponectin gene is expressed in multiple tissues in the chicken: food deprivation influences adiponectin messenger ribonucleic acid expression. Endocrinology. 2005; 146(10):4250-6. Epub 2005/06/25. en.2005-0254 [pii] doi: 10.1210/ en.2005-0254 PMID: 15976057.
13. Fry M, Smith PM, Hoyda TD, Duncan M, Ahima RS, Sharkey KA, et al. Area postrema neurons are modulated by the adipocyte hormone adiponectin. J Neurosci. 2006; 26(38):9695-702. Epub 2006/09/22. 26/38/9695 [pii] doi: 10.1523/JNEUROSCI.2014-06.2006 PMID: 16988040.
14. Rodriguez-Pacheco F, Martinez-Fuentes AJ, Tovar S, Pinilla L, Tena-Sempere M, Dieguez C, et al. Regulation of pituitary cell function by adiponectin. Endocrinology. 2007; 148(1):401-10. Epub 2006/ 10/14. en.2006-1019 [pii] doi: 10.1210/en.2006-1019 PMID: 17038552.
15. Coope A, Milanski M, Araujo EP, Tambascia M, Saad MJ, Geloneze B, et al. AdipoR1 mediates the anorexigenic and insulin/leptin-like actions of adiponectin in the hypothalamus. FEBS letters. 2008; 582(10):1471-6. Epub 2008/04/09. doi: 10.1016/j.febslet.2008.03.037 PMID: 18394428.
16. Hoyda TD, Smith PM, Ferguson AV. Adiponectin acts in the nucleus of the solitary tract to decrease blood pressure by modulating the excitability of neuropeptide Y neurons. Brain Res. 2009; 1256:76-84. Epub 2008/12/24. S0006-8993(08)02906-5 [pii] doi: 10.1016/j.brainres.2008.12.012 PMID: 19103175.
17. Psilopanagioti A, Papadaki H, Kranioti EF, Alexandrides TK, Varakis JN. Expression of adiponectin and adiponectin receptors in human pituitary gland and brain. Neuroendocrinology. 2009; 89(1):38-47. Epub 2008/08/14. 000151396 [pii] doi: 10.1159/000151396 PMID: 18698133.
18. Iannitti T, Graham A, Dolan S. Increased central and peripheral inflammation and inflammatory hyperalgesia in Zucker rat model of leptin receptor deficiency and genetic obesity. Experimental physiology. 2012. Epub 2012/04/24. doi: 10.1113/expphysiol.2011.064220 PMID: 22523380.
19. Kilkenny C, Browne WJ, Cuthi I, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. Veterinary clinical pathology / American Society for Veterinary Clinical Pathology. 2012; 41(1):27-31. Epub 2012/03/07. doi: 10.1111/j.1939-165X.2012. 00418.x PMID: 22390425.
20. Biddlestone L, Corbett AD, Dolan S. Oral administration of Ginkgo biloba extract, EGb-761 inhibits thermal hyperalgesia in rodent models of inflammatory and post-surgical pain. Br J Pharmacol. 2007; 151 (2):285-91. doi: 10.1038/sj.bjp.0707220 PMID: 17375081; PubMed Central PMCID: PMC2013958.
21. Dolan S, Kelly JG, Monteiro AM, Nolan AM. Up-regulation of metabotropic glutamate receptor subtypes 3 and 5 in spinal cord in a clinical model of persistent inflammation and hyperalgesia. Pain. 2003; 106 (3):501-12. Epub 2003/12/09. PMID: 14659534.
22. Phillips SA, Kung JT. Mechanisms of adiponectin regulation and use as a pharmacological target. Current opinion in pharmacology. 2010; 10(6):676-83. Epub 2010/09/03. doi: 10.1016/j.coph.2010.08.002 PMID: 20810317.
23. Wang Y, Lam KS, Yau MH, Xu A. Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem J. 2008; 409(3):623-33. Epub 2008/01/08. doi: 10.1042/BJ20071492 PMID: 18177270.
24. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006; 17(1):4-12. Epub 2006/04/15. PMID: 16613757.
25. Brochu-Gaudreau K, Rehfeldt C, Blouin R, Bordignon V, Murphy BD, Palin MF. Adiponectin action from head to toe. Endocrine. 2010; 37(1):11-32. Epub 2010/10/22. doi: 10.1007/s12020-009-9278-8 PMID: 20963555.
26. Hug C, Wang J, Ahmad NS, Bogan JS, Tsao TS, Lodish HF. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci U S A. 2004; 101 (28):10308-13. Epub 2004/06/24. doi: 10.1073/pnas.04033821010403382101 [pii]. PMID: 15210937.
27. Kudriashova E, Bashtrykov PP, Ivanov DB, Antropova Iu G, Il'inskaia OP, Tararak EM, et al. [Expression of T-cadherin in the rat carotid artery wall after balloon injury and in different rat organs]. Tsitologiia. 2002; 44(3):285-95. Epub 2002/07/04. PMID: 12094767.
28. Yamaguchi N, Argueta JG, Masuhiro Y, Kagishita M, Nonaka K, Saito T, et al. Adiponectin inhibits Tolllike receptor family-induced signaling. FEBS letters. 2005; 579(30):6821-6. Epub 2005/12/06. doi: 10. 1016/j.febslet.2005.11.019 PMID: 16325814.
29. Klein I, Sanchez-Alavez M, Tabarean I, Schaefer J, Holmberg KH, Klaus J, et al. AdipoR1 and 2 are expressed on warm sensitive neurons of the hypothalamic preoptic area and contribute to central hyperthermic effects of adiponectin. Brain Res. 2011; 1423:1-9. Epub 2011/10/18. doi: 10.1016/j. brainres.2011.09.019 PMID: 22000082; PubMed Central PMCID: PMC3215583.
30. Cui J, Panse S, Falkner B. The role of adiponectin in metabolic and vascular disease: a review. Clin Nephrol. 2011; 75(1):26-33. Epub 2010/12/24. 8249 [pii]. PMID: 21176748.
31. Morinigo R, Musri M, Vidal J, Casamitjana R, Delgado S, Lacy AM, et al. Intra-abdominal fat adiponectin receptors expression and cardiovascular metabolic risk factors in obesity and diabetes. Obes Surg. 2006; 16(6):745-51. Epub 2006/06/08. doi: 10.1381/096089206777346736 PMID: 16756736.
32. Rasmussen MS, Lihn AS, Pedersen SB, Bruun JM, Rasmussen M, Richelsen B. Adiponectin receptors in human adipose tissue: effects of obesity, weight loss, and fat depots. Obesity (Silver Spring). 2006; 14(1):28-35. Epub 2006/02/24. 14/1/28 [pii]doi: 10.1038/oby.2006.5 PMID: 16493120.
33. Zhou Y, Sun X, Jin L, Stringfield T, Lin L, Chen Y. Expression profiles of adiponectin receptors in mouse embryos. Gene expression patterns: GEP. 2005; 5(5):711-5. doi: 10.1016/j.modgep.2005.02. 002 PMID: 15939384.
34. Qi Y, Takahashi N, Hileman SM, Patel HR, Berg AH, Pajvani UB, et al. Adiponectin acts in the brain to decrease body weight. Nat Med. 2004; 10(5):524-9. Epub 2004/04/13. doi: 10.1038/nm1029nm1029 [pii]. PMID: 15077108.
35. Hoyda TD, Ferguson AV. Adiponectin modulates excitability of rat paraventricular nucleus neurons by differential modulation of potassium currents. Endocrinology. 2010; 151(7):3154-62. Epub 2010/05/07. doi: 10.1210/en.2009-1390 PMID: 20444939.
36. Kitagawa J, Takeda M, Suzuki I, Kadoi J, Tsuboi Y, Honda K, et al. Mechanisms involved in modulation of trigeminal primary afferent activity in rats with peripheral mononeuropathy. Eur J Neurosci. 2006; 24 (7):1976-86. Epub 2006/10/17. doi: 10.1111/j.1460-9568.2006.05065.x PMID: 17040479.
37. Lawson K, McKay NG. Modulation of potassium channels as a therapeutic approach. Current pharmaceutical design. 2006; 12(4):459-70. Epub 2006/02/14. PMID: 16472139.
38. Roza C, Lopez-Garcia JA. Retigabine, the specific KCNQ channel opener, blocks ectopic discharges in axotomized sensory fibres. Pain. 2008; 138(3):537-45. Epub 2008/03/12. doi: 10.1016/j.pain.2008.01. 031 PMID: 18331780.
39. Xu W, Wu Y, Bi Y, Tan L, Gan Y, Wang K. Activation of voltage-gated KCNQ/Kv7 channels by anticonvulsant retigabine attenuates mechanical allodynia of inflammatory temporomandibular joint in rats. Mol Pain. 2010; 6:49. Epub 2010/08/28. doi: 10.1186/1744-8069-6-49 PMID: 20796319; PubMed Central PMCID: PMC2936374.
40. Fantuzzi G. Adiponectin in inflammatory and immune-mediated diseases. Cytokine. 2013; 64(1):1-10. Epub 2013/07/16. doi: 10.1016/j.cyto.2013.06.317 PMID: 23850004; PubMed Central PMCID: PMC3770746.
41. Churi SB, Abdel-Aleem OS, Tumber KK, Scuderi-Porter H, Taylor BK. Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in rats. J Pain. 2008; 9(7):639-49. Epub 2008/04/05. S1526-5900(08)00417-3 [pii] doi: 10.1016/j.jpain.2008.02.002 PMID: 18387855.
42. Morgenweck J, Abdel-Aleem OS, McNamara KC, Donahue RR, Badr MZ, Taylor BK. Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema. Neuropharmacology. 2010; 58(2):337-45. Epub 2009/11/07. S0028- 3908(09)00339-6 [pii] doi: 10.1016/j.neuropharm.2009.10.008 PMID: 19891980.
43. Takahashi Y, Hasegawa-Moriyama M, Sakurai T, Inada E. The macrophage-mediated effects of the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuate tactile allodynia in the early phase of neuropathic pain development. Anesth Analg. 2011; 113(2):398-404. Epub 2011/ 04/15. ANE.0b013e31821b220c [pii] doi: 10.1213/ANE.0b013e31821b220c PMID: 21490083.
44. Beloeil H, Ji RR, Berde CB. Effects of bupivacaine and tetrodotoxin on carrageenan-induced hind paw inflammation in rats (Part 2): cytokines and p38 mitogen-activated protein kinases in dorsal root ganglia and spinal cord. Anesthesiology. 2006; 105(1):139-45. Epub 2006/07/01. 00000542-200607000-00023 [pii]. PMID: 16810005.
45. Huber JD, Campos CR, Mark KS, Davis TP. Alterations in blood-brain barrier ICAM-1 expression and brain microglial activation after lambda-carrageenan-induced inflammatory pain. Am J Physiol Heart Circ Physiol. 2006; 290(2):H732-40. Epub 2005/10/04. 00747.2005 [pii] doi: 10.1152/ajpheart.00747. 2005 PMID: 16199477.
46. Sekut L, Menius JA Jr, Brackeen MF, Connolly KM. Evaluation of the significance of elevated levels of systemic and localized tumor necrosis factor in different animal models of inflammation. J Lab Clin Med. 1994; 124(6):813-20. Epub 1994/12/01. 0022-2143(94)90044-2 [pii]. PMID: 7798795.